Cargando…

Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4‐mediated calcium entry in microglia

Microglia‐mediated inflammation exerts adverse effects in ischemic stroke and in neurodegenerative disorders such as Alzheimer's disease (AD). Expression of the voltage‐gated potassium channel Kv1.3 is required for microglia activation. Both genetic deletion and pharmacological inhibition of Kv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Hai M., di Lucente, Jacopo, Chen, Yi‐Je, Cui, Yanjun, Ibrahim, Rania H., Pennington, Michael W., Jin, Lee‐Way, Maezawa, Izumi, Wulff, Heike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540709/ https://www.ncbi.nlm.nih.gov/pubmed/32525239 http://dx.doi.org/10.1002/glia.23847

Ejemplares similares

Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
por: Chen, Yi‐Je, et al.
Publicado: (2017)

Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia
por: Nguyen, Hai M., et al.
Publicado: (2016)

The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion
por: Chen, Yi‐Je, et al.
Publicado: (2021)

Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling
por: Fomina, Alla F., et al.
Publicado: (2020)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)

Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke
por: Lee, Ruth D., et al.
Publicado: (2023)

Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy
por: Zhang, Xinyi, et al.
Publicado: (2022)

Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma
por: Grimaldi, Alfonso, et al.
Publicado: (2018)

Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer’s disease
por: Tang, Xinyu, et al.
Publicado: (2023)

Predominant Functional Expression of Kv1.3 by Activated Microglia of the Hippocampus after Status epilepticus
por: Menteyne, Alexis, et al.
Publicado: (2009)

The biophysical basis of excitability /
por: Ferreira, Hugo Gil
Publicado: (1985)

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
por: Maezawa, Izumi, et al.
Publicado: (2012)

Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function
por: Jena, Prasant Kumar, et al.
Publicado: (2020)

The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule
por: Maezawa, Izumi, et al.
Publicado: (2017)

Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes
por: Ren, Yunzhao R., et al.
Publicado: (2008)

Inhibition of store-operated calcium entry in microglia by helminth factors: implications for immune suppression in neurocysticercosis
por: Sun, Yuyang, et al.
Publicado: (2014)

The physical basis of biochemistry: the foundations of molecular biophysics
por: Bergethon, Peter R
Publicado: (1998)

Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis
por: Markakis, Ioannis, et al.
Publicado: (2021)

Cholesterol, Amyloid Beta, Fructose, and LPS Influence ROS and ATP Concentrations and the Phagocytic Capacity of HMC3 Human Microglia Cell Line
por: Muñoz Herrera, Oscar M., et al.
Publicado: (2023)

Structural basis of gating modulation of Kv4 channel complexes
por: Kise, Yoshiaki, et al.
Publicado: (2021)

A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3
por: Bednenko, Janna, et al.
Publicado: (2018)

The Mitochondrial Routing of the Kv1.3 Channel
por: Capera, Jesusa, et al.
Publicado: (2022)

The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer
por: Comes, Núria, et al.
Publicado: (2013)

Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
por: Pennington, Michael W., et al.
Publicado: (2015)

Microglia in Alzheimer's Disease
por: Jin, Lee-Way
Publicado: (2012)

Bronchospasm and its biophysical basis in airway smooth muscle
por: Fredberg, Jeffrey J
Publicado: (2004)

The basis of sharp spike onset in standard biophysical models
por: Telenczuk, Maria, et al.
Publicado: (2017)

Biophysical Basis of Alpha Rhythm Disruption in Alzheimer’s Disease
por: Sharma, Rohan, et al.
Publicado: (2020)

Molecular and biophysical basis of glutamate and trace metal modulation of voltage-gated Ca(v)2.3 calcium channels
por: Shcheglovitov, Aleksandr, et al.
Publicado: (2012)

Molecular and biophysical basis of glutamate and trace metal modulation of voltage-gated Ca(v)2.3 calcium channels
por: Shcheglovitov, Aleksandr, et al.
Publicado: (2012)

The C-terminal HRET sequence of Kv1.3 regulates gating rather than targeting of Kv1.3 to the plasma membrane
por: Voros, Orsolya, et al.
Publicado: (2018)

KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis
por: Tanner, Mark R., et al.
Publicado: (2019)

Heteromeric Channels Formed From Alternating Kv7.4 and Kv7.5 α-Subunits Display Biophysical, Regulatory, and Pharmacological Characteristics of Smooth Muscle M-Currents
por: Brueggemann, Lyubov I., et al.
Publicado: (2020)

Are there superagonists for calcium-activated potassium channels?
por: Brown, Brandon M., et al.
Publicado: (2017)

Auxiliary subunits control biophysical properties and response to compound NS5806 of the Kv4 potassium channel complex
por: Zhang, Hongxue, et al.
Publicado: (2019)

Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
por: Bergmann, Ralf, et al.
Publicado: (2017)

A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis
por: Wang, Yuqing, et al.
Publicado: (2023)

Klaviersonaten, KV 310, KV 333, KV 545
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1989)

Capacitative calcium entry: sensing the calcium stores
por: Putney, James W.
Publicado: (2005)

Historical contingency and its biophysical basis in glucocorticoid receptor evolution
por: Harms, Michael J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pn9vng1agtiefpqfis8lhb6l01